Christopher Graffeo to Protein Kinase Inhibitors
This is a "connection" page, showing publications Christopher Graffeo has written about Protein Kinase Inhibitors.
Connection Strength
0.901
-
Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review. J Neurooncol. 2025 Oct 30; 176(1):58.
Score: 0.860
-
Dramatic Growth of a Vestibular Schwannoma After 16 Years of Postradiosurgery Stability in Association With Exposure to Tyrosine Kinase Inhibitors. Otol Neurotol. 2021 12 01; 42(10):e1609-e1613.
Score: 0.041